The Effect of Gallstone Characteristics for the Severity of Gallstone Pancreatitis
1 other identifier
observational
301
1 country
1
Brief Summary
The purpose of this study was to determine the effect of gallstone characteristics for the severity of acute gallstone pancreatitis (GSP)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2022
CompletedStudy Start
First participant enrolled
August 10, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 24, 2023
CompletedSeptember 26, 2023
September 1, 2023
1.1 years
August 10, 2022
September 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of severity of GSP patients
Based on the 2012 Atlanta International Consensus, Mild acute pancreatitis (MAP) is defined as no organ failure and no local or systemic complications. Moderate to severe acute pancreatitis (MSAP) refers to patients with organ failure, local complications, or aggravated complications. Severe acute pancreatitis (SAP) is defined as persistent organ failure for more than 48 hours.
1 month
Secondary Outcomes (3)
Modified computed tomography severity index (MCTSI) score
1 month
Gallstone size
1 month
Number of stones
1 month
Interventions
stone size, number, the thickness
Eligibility Criteria
Acute gallstone pancreatitis patients
You may qualify if:
- Acute gallstone pancreatitis (GSP) patients.
You may not qualify if:
- Pancreatitis with bile duct stones, trauma, drugs, and surgery;
- Recurrent gallstone pancreatitis;
- Combined with other malignant tumors, such as liver cancer, cholangiocarcinoma, pancreatic cancer, gastric cancer, Hematologic tumor, and lymphoma;
- Previous hepatobiliary and pancreatic surgery, Organ transplantation;
- Intestinal obstruction or other obstructive diseases;
- Chronic pancreatitis or pancreatic duct stones;
- Thrombotic disease;
- Alcoholic pancreatitis and hyperlipidemia pancreatitis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, 730000, China
Related Publications (3)
Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013 Jun;144(6):1252-61. doi: 10.1053/j.gastro.2013.01.068.
PMID: 23622135BACKGROUNDBoxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, van Santvoort HC, Besselink MG. Acute pancreatitis. Lancet. 2020 Sep 5;396(10252):726-734. doi: 10.1016/S0140-6736(20)31310-6.
PMID: 32891214BACKGROUNDMa Y, Yue P, Zhang J, Yuan J, Liu Z, Chen Z, Zhang H, Zhang C, Zhang Y, Dong C, Lin Y, Liu Y, Li S, Meng W. Early prediction of acute gallstone pancreatitis severity: a novel machine learning model based on CT features and open access online prediction platform. Ann Med. 2024 Dec;56(1):2357354. doi: 10.1080/07853890.2024.2357354. Epub 2024 May 30.
PMID: 38813815DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wenbo Meng, M.D.,Ph.D
LanZhou University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of surgery
Study Record Dates
First Submitted
August 10, 2022
First Posted
August 12, 2022
Study Start
August 10, 2022
Primary Completion
September 24, 2023
Study Completion
September 24, 2023
Last Updated
September 26, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
If patients permitted